Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
72 studies found for:    trabectedin
Show Display Options
Rank Status Study
1 Recruiting Retrospective Study of Trabectedin in Soft Tissue Sarcomas
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Trabectedin
2 Recruiting Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
Conditions: Liposarcoma;   Leiomyosarcoma
Intervention: Drug: Trabectedin
3 Recruiting ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: Trabectedin
4 Recruiting Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin
Condition: Sarcoma
Interventions: Drug: Trabectedin;   Genetic: DNA double-strand breaks
5 Completed
Has Results
A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram
Condition: Solid Tumor
Interventions: Drug: Trabectedin;   Drug: Placebo
6 Unknown  Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer
Condition: BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype
Intervention: Drug: Trabectedin
7 Recruiting Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: trabectedin
8 Active, not recruiting A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Condition: Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Interventions: Drug: Trabectedin;   Drug: Dacarbazine
9 Not yet recruiting Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26
Conditions: Carcinosarcoma, Ovarian;   Carcinosarcomas Uterine
Intervention: Drug: Trabectedin
10 Active, not recruiting Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)
Conditions: Soft Tissue Sarcoma;   Bone Tumor
Interventions: Drug: trabectedin;   Drug: olaparib
11 Completed Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas
Conditions: Leiomyosarcoma;   Liposarcoma
Intervention: Drug: Gemcitabine + Trabectedin
12 Not yet recruiting Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.
Conditions: Ovarian Carcinoma;   Soft Tissue Sarcoma
Intervention: Drug: Combination of trabectedin with durvalumab
13 Completed A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Trabectedin
14 Recruiting Trabectedin for Recurrent Grade II/III Meningioma
Condition: Recurrent High Grade Meningioma
Interventions: Drug: Trabectedin;   Other: Local standard of care
15 Completed
Has Results
ET 743 (Yondelis) in Men With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: ET 743
16 Active, not recruiting Trabectedin First Line Therapy In Unfit Sarcoma Study
Conditions: Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive;   Standard Chemotherapy
Intervention: Drug: Trabectedin
17 Completed A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Conditions: Neoplasm Metastases;   Hepatic Insufficiency
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
18 Recruiting Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Condition: Ovarian Epithelial Cancer Recurrent
Interventions: Drug: bevacizumab and trabectedin;   Drug: bevacizumab, trabectedin and carboplatin
19 Not yet recruiting Trabectedin Maintenance Post 1st-line in STS
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Trabectedin
20 Terminated Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
Condition: Sarcoma
Interventions: Drug: Doxorubicin;   Drug: Trabectedin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.